AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

REPLIGEN CORP Director's Dealing 2023

Dec 16, 2023

30826_dirs_2023-12-15_7ef2110e-e25e-4fb5-b9b4-90ebafd4597c.zip

Director's Dealing

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2023-05-18

Reporting Person: EGLINTON MANNER CARRIE (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2792	Direct